J Sosman
Overview
Explore the profile of J Sosman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson A, Macgowan R, Eldridge G, Morrow K, Sosman J, Zack B, et al.
AIDS Behav
. 2011 Nov;
17(8):2676-84.
PMID: 22124581
The objectives of this study were to: (a) estimate the costs of providing a single-session HIV prevention intervention and a multi-session intervention, and (b) estimate the number of HIV transmissions...
2.
Fisher D, Barnhill R, Hodi F, Herlyn M, Merlino G, Medrano E, et al.
Pigment Cell Melanoma Res
. 2009 Dec;
23(1):14-26.
PMID: 20025711
No abstract available.
3.
Van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M, et al.
Bone Marrow Transplant
. 2003 Jun;
32(1):9-13.
PMID: 12815472
Fludarabine, thiotepa and total body irradiation (TBI) has been used as conditioning in haplo-identical transplantation. We studied this conditioning regimen in adults undergoing matched sibling transplantation and alternative donor transplantation....
4.
Margolin K, Atkins B, Thompson A, Ernstoff S, Weber J, Flaherty L, et al.
J Cancer Res Clin Oncol
. 2002 Apr;
128(4):214-8.
PMID: 11935312
Purpose: To evaluate the antitumor effects and toxicities of whole brain irradiation (WBI) with temozolomide (TMZ) administered by prolonged oral dosing in patients with melanoma metastatic to the brain. Background:...
5.
Dutcher J, Atkins M, Margolin K, Weiss G, Clark J, Sosman J, et al.
Med Oncol
. 2002 Mar;
18(3):209-19.
PMID: 11917945
The Cytokine Working Group (CWG) was initially established in 1986 as the Extramural IL-2/LAK Working Group. With funding from the National Cancer Institute (NCI), the CWG was mandated to confirming...
6.
Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trials
Atkins M, Dutcher J, Weiss G, Margolin K, Clark J, Sosman J, et al.
Med Oncol
. 2002 Mar;
18(3):197-207.
PMID: 11917944
The Cytokine Working Group (CWG) was initially established in 1986 as the Extramural IL-2/LAK Working Group. With funding from the National Cancer Institute (NCI), the CWG was mandated to confirming...
7.
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer
Brockstein B, SAMUELS B, Humerickhouse R, Arietta R, Fishkin P, Wade J, et al.
Invest New Drugs
. 2001 Sep;
19(3):249-54.
PMID: 11561683
Background: Bryostatin 1 is a marine derived macrolactone with antineoplastic activity modulated through protein kinase C, and with good activity in in vitro and in vivo models. There are few...
8.
Flaherty L, Atkins M, Sosman J, Weiss G, Clark J, Margolin K, et al.
J Clin Oncol
. 2001 Jul;
19(13):3194-202.
PMID: 11432886
Purpose: The Cytokine Working Group performed a randomized phase II trial of two outpatient biochemotherapy regimens to identify an outpatient regimen with high antitumor activity and less toxicity than inpatient...
9.
Atkins M, Redman B, Mier J, Gollob J, Weber J, Sosman J, et al.
Clin Cancer Res
. 2001 Apr;
7(3):486-92.
PMID: 11297238
CNI-1493, an inhibitor of proinflammatory cytokines, was studied in a Phase I trial in melanoma and renal cancer patients receiving high-dose interleukin 2 (IL-2). Objectives of the study were to...
10.
Dutcher J, Logan T, Gordon M, Sosman J, Weiss G, Margolin K, et al.
Clin Cancer Res
. 2000 Sep;
6(9):3442-50.
PMID: 10999727
The purpose of this study was to evaluate the potential efficacy of alternating two outpatient regimens for the treatment of metastatic renal cell cancer. These regimens consisted of 4 weeks...